Aranding, Jaren Mae J.

HRN: 25-63-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2024
CEFAZOLIN 1GM (VIAL)
08/09/2024
08/16/2024
INTRAVENOUS
467 Mg
Every 8 Hours
To Consider Folliculitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: